Beruflich Dokumente
Kultur Dokumente
IPOs are down from last year, though. Year-to-date through Q3'16 saw 28 medical device M&As and
2 IPOs.
The medical device industry has received a relatively steady flow of funding since 2012, with 2016 on
pace to record $3.5B in financing to private companies, helped along by crossover investors those
like mutual funds normally focused on public markets that have become increasingly active in the
space.
Exits are also on track for a strong year. While theres been a slowdown in total number of medical
device IPOs this year, 2016 already reached a high in M&A activity. And this year is likely to top last
year for total exits in the sector.
We used CB Insights data to analyze exit trends for the medical device industry, as well as identify
the largest medical device exits and top acquirers in the space.
Exit activity
Exit activity in the medical device space has been trending upwards, with 60% growth observed in
2015. Since 2012, there have been 96 first exits 77 M&A exits and 19 IPOs.
As of Q316, the industry has seen 30 exits this year, 28 M&A and 2 IPOs. Pulse Biosciences, a
development-stage device company working on an electric signaling platform with potential
oncological applications, went public in May of this year valued at $50M. And in July, Tactile
Systems, focused on therapeutic devices for chronic swelling, went public at a $166M valuation.
The most active acquirer in the medical device industry was Medtronic with 8 acquisitions since
2012. Top acquirers were typically attracted to companies focused on the cardiovascular system.
Five of Medtronics 7 acquisitions, TWELVE, Aptus Endosystems, and Medina Medical, were
cardiovascular-based companies.
In a distant second were Abbott Laboratories and St. Jude Medical, with 3 acquisitions each. Again, 5
of these 6 acquisitions were in cardiovascular-focused companies, including Topera Medical and
Endosense.
Source: cbinsights.com
rcase31@aim.com
https://www.linkedin.com/in/rcase1/